As an unusual interleukin that induces the production of antibacterial proteins and specific chemokines, IL-22 has been shown to ameliorate pancreatitis, hepatitis, inflammatory bowel disease, ulcerative colitis and diabetic wounds [30–32]. Here, IL22 is linked to hepatitis A virus infection.